MORGAN STANLEY PLC/CALL/STRYKER CORP./340/0.1/20.12.24 Share Price

Warrant

DE000MB35HB7

Real-time Bid/Ask 04:43:30 21/06/2024 pm IST
2.52 EUR / 2.57 EUR -1.74% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./340/0.1/20.12.24
Current month+6.58%
1 month+30.81%
Date Price Change
21/24/21 2.5 -3.47%
20/24/20 2.59 -17.25%
19/24/19 3.13 +7.93%
18/24/18 2.9 +9.02%
17/24/17 2.66 +2.31%

Delayed Quote Börse Stuttgart

Last update June 21, 2024 at 01:49 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB35HB
ISINDE000MB35HB7
Date issued 02/02/2023
Strike 340 $
Maturity 20/12/2024 (183 Days)
Parity 10 : 1
Emission price 1.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.56
Lowest since issue 0.85
Spread 0.05
Spread %1.95%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.4 USD
Average target price
372.9 USD
Spread / Average Target
+9.25%
Consensus